Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion type Assertion NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_head.
- NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion description "[The cross-talk between the PI3K-AKT and ER beta pathways, as revealed by the ability of AKT to regulate several components of ER beta-mediated transcription, may represent an important aspect that may influence breast cancer response to endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_provenance.
- NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion evidence source_evidence_literature NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_provenance.
- NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion SIO_000772 16951146 NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_provenance.
- NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion wasDerivedFrom befree-2016 NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_provenance.
- NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_assertion wasGeneratedBy ECO_0000203 NP567417.RA0I_NVl4X8tSXYatEbfaepCx1oRSbrgbKXl7MSflyCdg130_provenance.